|
Marché Fermé -
Nasdaq
22:00:00 28/08/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 244,54 USD | -2,61% |
|
-3,83% | +43,85% |
| 28/08 | L'action Jazz Pharmaceuticals dispose d'un potentiel de hausse supplémentaire, selon RBC | MT |
| 28/08 | Jazz Pharmaceuticals plc : RBC Capital Markets toujours positif | ZM |
Groupe Jazz Pharmaceuticals plc : Graphique Relationnel
Sociétés privées appartenant au même groupe que JAZZ PHARMACEUTICALS PLC
| Société | Dirigeant |
|---|---|
Jazz Securities DAC
 Jazz Securities DAC Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | - |
Jazz Investments II Ltd.
 Jazz Investments II Ltd. Finance/Rental/LeasingFinance Acts as a financing subsidiary/Special purpose entity | - |
Jazz Financing Holdings Ltd.
 Jazz Financing Holdings Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | - |
Jazz Investments Europe Ltd. | - |
Jazz Pharmaceuticals Ireland Ltd.
 Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the identification, development and commercialization of pharmaceutical products | Bruce Cozadd |
Jazz Financing I DAC
 Jazz Financing I DAC Finance/Rental/LeasingFinance Issues Asset-backed/Mortgage-backed/Structured Finance securities | - |
Jazz Pharmaceuticals Ireland Holdings Ltd. | - |
Jazz Financing Lux SARL
 Jazz Financing Lux SARL Finance/Rental/LeasingFinance Provides financing services | - |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
